We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BCLI market cap is 27.19M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.84M | -4.92M | -5.15M | -5.45M | -6.04M |
| Net Income | -6.86M | -5.02M | -5.06M | -5.33M | -1.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23M | -31.68M | -24.54M | -24.82M | -21.44M |
| Net Income | -23.25M | -31.81M | -24.46M | -24.28M | -17.19M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.25M | 8.45M | 7.87M | 5.75M | 5.68M |
| Total Liabilities | 11.87M | 11.47M | 12.71M | 9.63M | 8.26M |
| Total Equity | 1.39M | -3.02M | -4.84M | -3.88M | -2.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.53M | 51.26M | 29.28M | 8.45M | 4.21M |
| Total Liabilities | 18.76M | 15.8M | 9.94M | 11.47M | 9.07M |
| Total Equity | -12.22M | 35.46M | 19.34M | -3.02M | -4.86M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.67M | -19.32M | -3.99M | -10.76M | -17.17M |
| Investing | -40k | 998k | 2.01M | 2.01M | 2M |
| Financing | N/A | 238k | 3.23M | 8.53M | 15.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.25M | -35.19M | -26.27M | -19.32M | -20.46M |
| Investing | 5.62M | -4.45M | 323k | 998k | 2.19M |
| Financing | 5.23M | 76.94M | 6.97M | 238k | 18.98M |
| Market Cap | 27.19M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 48.98M |
| Average Volume (1 week) | 403.31k |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -80.10% |
| 52 Week High | 3.34 |
| 52 Week Low | 0.134 |
| Spread (Intraday) | 0.02 (3.82%) |
| Company Name | Brainstorm Cell Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.brainstorm-cell.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
